Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Fate Therapeutics (FATE) stocks in Canada
Learn how to easily invest in Fate Therapeutics stocks.
Fate Therapeutics is a biotechnology business based in the US. Fate Therapeutics stocks (FATE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $87.21 – a decrease of 3.69% over the previous week. Fate Therapeutics employs 390 staff and has a trailing 12-month revenue of around $54.7 million.
How to buy shares in Fate Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FATE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Fate Therapeutics?
- Has coronavirus impacted Fate Therapeutics shares?
- Fate Therapeutics shares summary
- Compare share dealing platforms
- Is Fate Therapeutics stock a buy or sell?
- Fate Therapeutics performance over time
- Fate Therapeutics's financials
- How volatile are Fate Therapeutics shares?
- Does Fate Therapeutics pay a dividend?
- Other common questions
Fate Therapeutics stock price (NASDAQ:FATE)Use our graph to track the performance of FATE stocks over time.
Fate Therapeutics shares at a glance
|Latest market close||$35.78|
|52-week range||$33.69 - $118.14|
|50-day moving average||$52.70|
|200-day moving average||$69.86|
|Wall St. target price||$99.44|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.12|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Fate Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Fate Therapeutics price performance over time
|1 week (2022-01-17)||N/A|
|1 month (2021-12-24)||N/A|
|3 months (2021-10-28)||-36.08%|
|6 months (2021-07-28)||-57.82%|
|1 year (2021-01-28)||-60.64%|
|2 years (2020-01-28)||39.87%|
|3 years (2019-01-28)||159.28%|
|5 years (2017-01-27)||1,187.05%|
Fate Therapeutics financials
|Revenue TTM||$54.7 million|
|Gross profit TTM||$-94,189,000|
|Return on assets TTM||-14.05%|
|Return on equity TTM||-34.06%|
|Market capitalisation||$3.8 billion|
TTM: trailing 12 months
Fate Therapeutics share dividends
We're not expecting Fate Therapeutics to pay a dividend over the next 12 months.
Fate Therapeutics share price volatility
Over the last 12 months, Fate Therapeutics's shares have ranged in value from as little as $33.69 up to $118.14. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fate Therapeutics's is 1.4516. This would suggest that Fate Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Fate Therapeutics overview
Fate Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors, as well as ProTmune for the treatment of hematologic malignancies and rare genetic disorders. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc.
Stocks similar to Fate Therapeutics
Fate Therapeutics in the news
Brown Advisory Inc Buys Visa Inc, Alphabet Inc, Mastercard Inc, Sells Chegg Inc, Fair Isaac ...
Outperforming The S&P 500 By Trading The Top 10 Stocks From 40 Large Hedge Funds: Trading Update 1/22/2022
Earnings playbook: A complete guide to this week's reports, including the first of tech
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
Ask an Expert
You must be logged in to post a comment.